Stocktoria

Kalaris Therapeutics, Inc. KLRS

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-07-30

Kalaris Therapeutics, Inc. institutional holders

InvestorSharesValue% of company
RENAISSANCE TECHNOLOGIES LLC66,151$381,6910.29%
MILLENNIUM MANAGEMENT LLC59,534$343,5110.26%
TWO SIGMA INVESTMENTS, LP30,650$176,8500.13%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.